Vascular endothelial growth factor: Environmental controls and effects in angiogenesis

British Journal of Cancer

Volumn 74, Issue SUPPL. XXVII, 1996, Pages

  Hlatky, L ^a   Hahnfeldt, P ^a   Tsionou, C ^a   Coleman, C N ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Endothelial cell; Gene expression; Hypoxia; Wound healing

Indexed keywords

GROWTH FACTOR RECEPTOR; VASCULOTROPIN; ENDOTHELIAL CELL GROWTH FACTOR; LYMPHOKINE; PROTEIN TYROSINE KINASE; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; CELL PROLIFERATION; CONFERENCE PAPER; GENE EXPRESSION REGULATION; GENE INDUCTION; GLIOBLASTOMA; HUMAN; HYPOXIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR VASCULARIZATION; VASCULAR ENDOTHELIUM; WOUND HEALING; ANIMAL; CELL HYPOXIA; NEOVASCULARIZATION (PATHOLOGY); PHYSIOLOGY; RADIATION EXPOSURE; REVIEW;

ANIMALS; CELL HYPOXIA; ENDOTHELIAL GROWTH FACTORS; HUMANS; LYMPHOKINES; NEOVASCULARIZATION, PATHOLOGIC; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS; WOUND HEALING;

EID: 0029889701     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (50)

1. ADAMS GE AND STRATFORD IJ. (1994). Bioreductive drugs for cancer therapy: the search for tumour specificity. Int. J. Radiat. Oncol. Biol. Phys., 29, 231-238.
2. BOOCOCK CA, CHARNOCK-JONES DS, SHARKEY AM, MCLAREN J, BARKER PJ, WRIGHT KA, TWENTYMAN PR AND SMITH SK. (1995). Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma. J. Natl Cancer Inst., 87, 506-516.
3. 2+ and von Willebrand factor release in human endothelial cells. Am. J. Pathol., 138, 213-221.
4. BROWN LF, BERSE B, JACKMAN RW, TOGNAZZI K, MANSEAU EJ, DVORAK HF AND SENGER DR. (1993a). Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. Am. J. Pathol., 143, 1255-1262.
5. BROWN LF, BERSE B, JACKMAN RW, TOGNAZZI K, MANSEAU EJ, SENGER DR AND DVORAK HF. (1993b). Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastro-intestinal tract. Cancer Res., 53, 4727-4735.
6. BROWN LF, YEO K-T, BERSE B, YEO TK, SENGER DR, DVORAK HF AND VAN DE WATER L. (1992). Expression of vascular permeability factor/vascular endothelial growth factor (VPF/ VEGF) by epidermal keratinocytes during wound healing. J. Exp. Med., 176, 1375-1379.
7. BROWN JM AND GIACCIA AJ (1994). Tumour hypoxia: the picture has changed in the 1990s. Int. J. Radiat. Biol., 65, 95-102.
8. CONNOLLY DT. (1991). Vascular permeability factor: a unique regulator of blood vessel function. J. Cell. Biochem., 47, 219-223, 1991.
9. DEJANA E, LANGUINO LR, POLENTARUTTI N, BALCONI G, RYCKEWAERT JJ, LARRIEU MJ, DONATI MB, MANTOVANI A AND MARGUERIE G. (1985). Interaction between fibrinogen and cultured endothelial cells: induction of migration and specific binding. J. Clin. Invest., 75, 11-18.
10. DE VRIES C, ESCOBEDO JA, UENO H, HOUCK K, FERRARA N AND WILLIAMS LT. (1992). The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science, 255, 989-991.
11. DVORAK HF. (1986). Tumors: wounds that do not heal. Similarities between tumour stroma generation and wound healing. N. Engl. J. Med., 315, 1650-1659.
12. DVORAK HF, BROWN LF, DETMAR M AND DVORAK AM. (1995). Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am. J. Pathol., 146, 1029-1039.
13. FAN TP, JAGGAR R AND BICKNELL R. (1995). Controlling the vasculature: angiogenesis, anti-angiogenesis and vascular targeting of gene therapy. Trends Pharmacol. Sci., 16, 57-66.
14. FLAMME I, BREIER G AND RISAU W. (1995). Vascular endothelial growth factor (VEGF) and VEGF receptor 2 (flk-1) are expressed during vasculogenesis and vascular differentiation in the quail embryo. Dev. Biol., 169, 699-712.
15. FOLKMAN J AND SHING Y. (1992). Angiogenesis. J. Biol. Chem., 267, 10931-10934.
16. FOTSIS T, ZHANG Y, PEPPER MS, ADLERCREUTZ H, MONTESANO R. NAWROTH PP AND SCHWEIGERER L. (1994). The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth. Nature, 368, 237-239.
17. HASSOUN PM, YU FS, SHEDD AL, ZULUETA JJ, THANNICKAL VJ, LANZILLO JJ AND FANBURG BL. (1994). Regulation of endothelial cell xanthine dehydrogenase/xanthine oxidase gene expression by oxygen tension. Am. J. Physiol., 266, L163-L171.
18. HEACOCK CS AND SUTHERLAND RM. (1986). Induction characteristics of oxygen regulated proteins. Int. J. Radiat. Oncol. Biol. Phys., 12, 1287-1290.
19. HLATKY L, TSIONOU C, HAHNFELDT P AND COLEMAN CN. (1994). Mammary fibroblasts may influence breast tumour angiogenesis via hypoxia-induced vascular endothelial growth factor up-regulation and protein expression. Cancer Res., 54, 6083-6086.
20. HOUCK KA, LEUNG DW, ROWLAND AM, WINER J AND FERRARA N. (1992). Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J. Biol. Chem., 267, 26031-26037.
21. HU DE AND FAN T-P. (1995). Suppression of VEGF-induced angiogenesis by the protein tyrosine kinase inhibitor, lavendustin A. Br. J. Pharmacol., 114, 262-268.
22. JELKMANN W. (1994). Biology of erythropoietin. Clin. Invest., 72, s3-s10.
23. KENDALL RL AND THOMAS KA. (1993). Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc. Natl Acad. Sci. USA. 90, 10705-10709.
24. KIM KJ, LI B, WINER J, ARMANINI M, GILLETT N, PHILLIPS HS AND FERRARA N. (1993). Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature, 362, 841-844.
25. KOONG AC, CHEN EY, LEE AS, BROWN JM AND GIACCIA AJ. (1994). Increased cytotoxicity of chronic hypoxic cells by molecular inhibition of grp78 induction. Int. J. Radiat. Oncol. Biol. Phys., 28, 661-666.
26. KOUREMBANAS S, HANNAN RL AND FALLER DV. (1990). Oxygen tension regulates the expression of the platelet-derived growth factor-b chain gene in human endothelial cells. J. Clin. Invest., 86, 670-674.
27. LADOUX A AND FRELIN C. (1993). Hypoxia is a strong inducer of vascular endothelial growth factor mRNA expression in the heart. Biochem. Biophys. Res. Commun., 195, 1005-1010.
28. LI H, CHEN S-J, CHEN Y-F, MENG QC, DURAND J, OPARIL S AND ELTON TS. (1994). Enhanced endothelin-1 and endothelin receptor gene expression in chronic hypoxia. J. Appl. Physiol., 77, 1451-1459.
29. LONGO LD, PACKIANATHAN S, MCQUEARY JA, STAGG RB, BYUS CV AND CAIN CD. (1993). Acute hypoxia increases ornithine decarboxylase activity and polyamine concentrations in fetal rat brain. Proc. Natl Acad. Sci. USA, 90, 692-696.
30. LUSCHER TF AND WENZEL RR. (1995). Endothelin and endothelin antagonists: pharmacology and clinical implications. Agents Actions, 45 (suppl.), 237-253.
31. MILLAUER B, WIZIGMANN-VOOS S, SCHNURCH H, MARTINEZ R, MOLLER NPH, RISAU W AND ULLRICH A. (1993). High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell, 72, 835-846.
32. MUKHOPADHYAY D, TSIOKAS L, ZHOU X-M, FOSTER D, BRUGGE JS AND SUKHATME VP. (1995). Hypoxic induction of human vascular endothelial growth factor expression through c-src activation. Nature, 375, 577-581.
33. MURPHY BJ, LADEROUTE KR, CHIN RJ AND SUTHERLAND RM. (1994). Metallothionein IIA is up-regulated by hypoxia in human A431 squamous carcinoma cells. Cancer Res., 54, 5808-5810.
34. NICOSIA RF, TCHAO R AND LEIGHTON J. (1982). Histotypic angiogenesis in vitro: light microscopic, ultrastructural, and radioautographic studies. In Vitro, 18, 538-549.
35. O'REILLY MS, HOLMGREN L, SHING Y, CHEN C, ROSENTHAL RA, MOSES M, LANE WS, CAO Y, SAGE EH AND FOLKMAN J. (1994). Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell, 79, 315-328.
36. PAJUSOLA K, APRELIKOVA O, PELICCI G, WEICH H, CLAESSONWELSH L AND ALITALO K. (1994). Signalling properties of flt4, a proteolytically processed receptor tyrosine kinase related to two VEGF receptors. Oncogene, 9, 3545-3555.
37. PEPPER MS, FERRARA N, ORCI L AND MONTESANO R. (1991). Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem. Biophys. Res. Commun., 181, 902-906.
38. PETERS KG, DE VRIES C AND WILLIAMS LT. (1993). Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth. Proc. Natl Acad. Sci. USA, 90, 8915-8919.
39. PLATE KH, BREIER G, WEICH HA AND RISAU W. (1992). Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature, 359, 845-848.
40. SCIANDRA JJ, SUBJECK JR AND HUGHES CS. (1984). Induction of glucose-regulated proteins during anaerobic exposure and of heat-shock proteins after reoxygenation. Proc. Natl Acad. Sci. USA, 81, 4843-4847.
41. SENGER DR, PERRUZZI CA, FEDER J AND DVORAK HF. (1986). A highly conserved vascular permeability factor secreted by a variety of human and rodent tumour cell lines. Cancer Res., 46, 5629-5632.
42. SHWEIKI D, NEEMAN M, ITIN A AND KESHET E. (1995). Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumour angiogenesis. Proc. Natl Acad. Sci. USA, 92, 768-772.
43. TERMAN BI, DOUGHER-VERMAZEN M, CARRION ME, DIMITROV D. ARMELLINO DC, GOSPODAROWICZ D AND BOHLEN P. (1992). Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem. Biophys. Res. Commun., 187, 1579-1586.
44. TSIONOU CH, OLESIAK M, MINARETZIS D, HAHNFELDT P, HARRIS J, MARCUS KC AND HLATKY L. (1996). VEGF expression in MCF7 cells and human breast fibroblasts is influenced by tumour microenvironment in vitro. Breast Cancer Res. Treat., (in press).
45. UNEMORI EN, FERRARA N, BAUER EA AND AMENTO EP. (1992). Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells. J. Cell. Phys., 153, 557-562.
46. VAN MEIR EG, POLVERINI PJ, CHAZIN VR, SU HUANG HJ, DE TRIBOLET N AND CAVENEE WK. (1994). Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells. Nature Genet., 8, 171-176.
47. WALKER LJ, CRAIG RB, HARRIS AL AND HICKSON ID. (1994). A role for the human DNA repair enzyme HAP1 in cellular protection against DNA damaging agents and hypoxic stress. Nucleic Acids Res., 22, 4884-4889.
48. WEIDNER N, SEMPLE JP, WELCH WR AND FOLKMAN J. (1991). Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N. Engl. J. Med., 324, 1-8.
49. YEO TK AND DVORAK HF. (1995). Tumor Stroma. In Diagnostic Immunopathology, Colvin RB, Bhan AT and McCluskey RT. (eds). Chapter 36, pp. 685-697. Raven Press, Ltd: New York.
50. ZHANG HT, CRAFT P, SCOTT PA, ZICHE M, WEICH HA, HARRIS AL AND BICKNELL R. (1995). Enhancement of tumour growth and vascular density by transfection of vascular endothelial cell growth factor into MCF-7 human breast carcinoma cells. J. Natl Cancer Inst., 87, 213-219.